Skip to main content

Anagrelide use while Breastfeeding

Drugs containing Anagrelide: Agrylin

Medically reviewed by Drugs.com. Last updated on Jul 18, 2021.

Anagrelide Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of anagrelide during breastfeeding. The manufacturer recommends that the drug not be used during breastfeeding and for 1 week after the last dose.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Substance Identification

Substance Name

anagrelide

CAS Registry Number

68475-42-3

Drug Class

Breast Feeding

Lactation

Fibrinolytic Agents

Platelet Aggregation Inhibitors

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.